>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

January 12, 2012

Respironics, Inc. Trilogy 100 Ventilators: Class I Recall - Device May Stop Delivering Therapy to Patient

Summary:

FDA notified health care professionals of the Class 1 recall of this product due to a manufacturing issue can stop delivering therapy to the patient. Part of the blower that circulates air and other gases through the ventilator may move out of position and cause the device to alarm.  Failure to respond could result in the potential for harm or death of a ventilator-dependent patient.

January 12, 2012

Bedford Laboratories Vecuronium Bromide And Polymyxin B For Injection USP For Injection: Recall - Glass Particles

Summary:

Bedford Laboratories issued guidance on the nationwide voluntary product recalls originally issued on August 2, 2011. The recalls were initiated after the discovery of a visible glass particle in a limited number of vials within the lots listed.

January 09, 2012

Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk

Summary:

FDA is advising health care professionals and patients of a potential problem with opiate products manufactured and packaged for Endo Pharmaceuticals by Novartis Consumer Health at its Lincoln, Nebraska manufacturing site.

>

ASA FEATURED PRODUCT

Self-Education and Evaluation (SEE) Program

SKU: 30701-12CE

... Read more »

Single Copies, Member Price: $300

Update: Cuts in effect – Senate Reported to be Considering Free-Standing Six-Month “Fix” Bill

Friday, June 18, 2010

Since the House and Senate were unable to agree upon legislation that includes an SGR “fix,” a 21 percent Medicare payment cut is now in full effect. The reduction was officially instated as of June 1, but CMS had directed carriers to hold claims through yesterday, June 17. Now the Agency will begin to process claims with the 21 percent cut.

Earlier this week the Senate defeated two amendments to H.R. 4213, “The American Jobs and Closing Tax Loopholes Act,” that included SGR provisions:

  • Sen. Max Baucus (D-MT) offered an amendment that, among other provisions, provided for a 2.2 percent update through 2010 and a 1 percent update in 2011, with a 33 percent cut in 2012. The amendment was defeated by a vote of 45-52.
  • Sen. John Thune (R-SD) offered an amendment that, among other provisions, provided for a 2.0 percent update for 2010, 2011 and 2012, followed by massive cuts of more than 30 percent. The amendment failed by a vote of 41-57

As of Friday morning, Senate leadership is reported to be discussing a free-standing - not a part of the H.R. 4213 – “doc fix” bill providing for a 2.2 percent update starting June 1 and extending through November 30. If the Senate were to pass such a bill, relief for physician would not be available until the House of Representatives could also consider and pass the bill.

It is anticipated that Congress will ultimately pass some type of Medicare payment relief and that the implemented cuts will be temporary with retroactive payment adjustments likely.

ASA supports full repeal of the SGR with replacement by a mechanism that accurately reflects the costs of providing care. Short of full repeal, ASA supports proposals that 1) provide for appropriate payment updates; 2) do not exacerbate projected future payment cuts; and 3) begin to address the magnitude of the projected payment cuts – the “SGR debt.”

ASA is following the situation closely and will provide additional information as it becomes available.

« Back to Washington Alerts